Cite
Lehnert H, Castello-Bridoux C, Channaiah B, et al. Comparison of Safety Profiles of the New and Old Formulations of Levothyroxine in a First Global Introduction in France. Exp Clin Endocrinol Diabetes. 2021;129(12):908-917doi: 10.1055/a-1302-9343.
Lehnert, H., Castello-Bridoux, C., Channaiah, B., Martiniere, K., Hildemann, S., & Wémeau, J. L. (2021). Comparison of Safety Profiles of the New and Old Formulations of Levothyroxine in a First Global Introduction in France. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 129(12), 908-917. https://doi.org/10.1055/a-1302-9343
Lehnert, Hendrik, et al. "Comparison of Safety Profiles of the New and Old Formulations of Levothyroxine in a First Global Introduction in France." Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association vol. 129,12 (2021): 908-917. doi: https://doi.org/10.1055/a-1302-9343
Lehnert H, Castello-Bridoux C, Channaiah B, Martiniere K, Hildemann S, Wémeau JL. Comparison of Safety Profiles of the New and Old Formulations of Levothyroxine in a First Global Introduction in France. Exp Clin Endocrinol Diabetes. 2021 Dec;129(12):908-917. doi: 10.1055/a-1302-9343. Epub 2021 Jan 28. PMID: 33511579.
Copy
Download .nbib